FIBI:TASEFirst International Bank of Israel Ltd Analysis
Data as of 2026-06-13 - not real-time
ILA 29,960.00
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
F.I.B.I. Holdings trades at 29,960 ILA, just above the identified support of 28,600 and slightly below its 20‑day (30,275) and 50‑day (30,756) moving averages, suggesting a short‑term price ceiling. The RSI sits at 47, indicating a neutral momentum stance, while the MACD line remains beneath its signal with a negative histogram, flagging bearish short‑term pressure. Despite this technical backdrop, the stock's valuation appears attractive: a trailing P/E of 10.28 is well under the industry average of 16.83, and the price‑to‑book ratio of 1.5 aligns with a modest discount to book value. The dividend yield of 7.91% coupled with a payout ratio of 45% underscores a generous and potentially sustainable income stream, reinforced by a massive cash pile of 76.9 B ILA against 18.4 B ILA of debt. Low beta (0.31) points to limited systematic risk, yet the 30‑day volatility of 32% signals notable price swings. The DCF‑derived fair value of roughly 180,891 ILA implies a deep undervaluation relative to the current market price, further bolstering the case for a value‑oriented entry point.
In sum, the combination of a solid balance sheet, strong dividend yield, and clear valuation headroom outweighs the near‑term bearish technical signals, positioning FIBI as a compelling candidate for investors seeking stable income and upside potential.
In sum, the combination of a solid balance sheet, strong dividend yield, and clear valuation headroom outweighs the near‑term bearish technical signals, positioning FIBI as a compelling candidate for investors seeking stable income and upside potential.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price hovering just above the 28,600 support level
- Bearish MACD histogram indicating downward pressure
- High dividend yield of 7.91% providing income cushion
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Significant valuation gap (P/E 10.28 vs industry 16.83)
- Robust cash position and low leverage
- Market sentiment reflected by extreme greed index
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Sustainable dividend supported by a 45% payout ratio
- Low systematic risk (beta 0.31) and stable banking fundamentals
- Deep undervaluation indicated by DCF fair value far above price
Key Metrics & Analysis
Financial Health
Revenue Growth-1.80%
Profit Margin15.50%
P/E Ratio10.3
ROE15.49%
ROA0.88%
P/B Ratio1.5
Op. Cash FlowILA604.0M
Industry P/E16.8
Technical Analysis
TrendNeutral
RSI47.2
SupportILA 28,600.00
ResistanceILA 31,800.00
MA 20ILA 30,275.00
MA 50ILA 30,756.20
MA 200ILA 28,628.35
MACDBearish
VolumeIncreasing
Fear & Greed Index89.86
Valuation
Fair ValueILA 180,890.80
GradeUndervalued
TypeValue
Dividend Yield7.91%
Risk Assessment
Beta0.00
Volatility32.14%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.